1. Potential Benefits of Berberine in the Management of Perimenopausal Syndrome
   Cristiana Caliceti et al, 2015, Oxidative Medicine and Cellular Longevity CrossRef
2. Berberine Attenuates Myocardial Ischemia/Reperfusion Injury by Reducing Oxidative Stress and Inflammation Response: Role of Silent Information Regulator 1.
   Liming Yu et al, 2016, Oxid Med Cell Longev CrossRef
3. In Vivo and in Vitro Study on Drug-Drug Interaction of Lovastatin and Berberine from Pharmacokinetic and HepG2 Cell Metabolism Studies
   Hanming Cui et al, 2016, Molecules CrossRef
4. Isoquinoline Alkaloids and Indole Alkaloids Attenuate Aortic Atherosclerosis in Apolipoprotein E Deficient Mice: A Systematic Review and Meta-Analysis
   Yibing Zhang et al, 2018, Front. Pharmacol. CrossRef
5. Co-delivery of LOX-1 siRNA and statin to endothelial cells and macrophages in the atherosclerotic lesions by a dual-targeting core-shell nanoplatform: A dual cell therapy to regress plaques
   Yi Zhao et al, 2018, Journal of Controlled Release CrossRef
6. Berberine in combination with cisplatin suppresses breast cancer cell growth through induction of DNA breaks and caspase-3-dependent apoptosis
   YUWAN ZHAO et al, 2016 CrossRef
7. Berberis Vulgarisand Berberine: An Update Review
   Mohsen Imenshahidi et al, 2016, Phytother. Res. CrossRef
8. Berberine and Its Role in Chronic Disease
   Arrigo F. G. Cicero et al, 2016 CrossRef
9. Novel role of the nutraceutical bioactive compound berberine in lectin-like OxLDL receptor 1-mediated endothelial dysfunction in comparison to lovastatin
   C. Caliceti et al, 2017, Nutrition, Metabolism and Cardiovascular Diseases CrossRef
10. Targeting Foam Cell Formation in Atherosclerosis: Therapeutic Potential of Natural Products.
    Dongdong Wang et al, 2019, Pharmacol Rev CrossRef
11. Berberine activates caspase-9/cytochrome c -mediated apoptosis to suppress triple-negative breast cancer cells in vitro and in vivo
    Yuwan Zhao et al, 2017, Biomedicine & Pharmacotherapy CrossRef
12. Coptisine from Coptis chinensis exerts diverse beneficial properties: A concise review.
    Jiasi Wu et al, 2019, J Cell Mol Med CrossRef
13. Berberine alleviates monosodium glutamate induced postnatal metabolic disorders associated vascular endothelial dysfunction in newborn rats: possible role of matrix metalloproteinase-1
    Abeer A. Abo Zeid et al, 2020, Archives of Physiology and Biochemistry CrossRef
14. High‐dose atorvastatin improves vascular endothelial function in patients with leukoaraiosis
    Jianan Xue et al, 2020, J Clin Lab Anal CrossRef
15. A randomized, multicenter and noninferiority study of amoxicillin plus berberine vs tetracycline plus furazolidone in quadruple therapy for Helicobacter pylori rescue treatment.
    Jian Zhang et al, 2020, J Dig Dis CrossRef
16. Promising Anti-atherosclerotic Effect of Berberine: Evidence from In Vitro, In Vivo, and Clinical Studies
    Alireza Fatahian et al, 2020 CrossRef
17. A New Therapeutic Candidate for Cardiovascular Diseases: Berberine
    Yun Cai et al, 2021, Front. Pharmacol. CrossRef
18. Chinese Herbal Medicines and Active Metabolites: Potential Antioxidant Treatments for Atherosclerosis
    Luxia Song et al, 2021, Front. Pharmacol. CrossRef
19. Atheroprotective Effects and Molecular Mechanism of Berberine
    Lu Xing et al, 2021, Front. Mol. Biosci. CrossRef
20. Vascular Protective Effect and Its Possible Mechanism of Action on Selected Active Phytocompounds: A Review
    Nur Aqilah Kamaruddin et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
21. Natural products: potential therapeutic agents for atherosclerosis
    Xiaobei CHENG et al, 2022, Chinese Journal of Natural Medicines CrossRef
22. Effects of adjuvant berberine therapy on acute ischemic stroke: A meta‐analysis
    Dan Luo et al, 2023, Phytotherapy Research CrossRef
23. Efficacy and underlying mechanisms of berberine against lipid metabolic diseases: a review
    Yajie Cai et al, 2023, Front. Pharmacol. CrossRef